Filing Details
- Accession Number:
- 0001179110-20-011606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-03 16:10:23
- Reporting Period:
- 2020-12-01
- Accepted Time:
- 2020-12-03 16:10:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769740 | Ariel Hurley | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-01 | 138 | $109.08 | 9,984 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-12-01 | 900 | $8.80 | 10,884 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-01 | 900 | $110.00 | 9,984 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-01 | 900 | $0.00 | 900 | $8.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,964 | 2025-02-10 | No | 4 | M | Direct |
Footnotes
- Effected pursuant to a trading plan adopted on March 17, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Consists of 138 shares that were acquired under the Issuer's employee stock purchase plan on November 30, 2020.
- This option was granted on February 10, 2015 and is fully vested as of the date hereof.